vs
Side-by-side financial comparison of AbbVie (ABBV) and CBRE Group (CBRE). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($15.0B vs $10.5B, roughly 1.4× CBRE Group). AbbVie runs the higher net margin — 4.6% vs 3.0%, a 1.6% gap on every dollar of revenue. On growth, CBRE Group posted the faster year-over-year revenue change (22.0% vs 9.9%). Over the past eight quarters, CBRE Group's revenue compounded faster (13.0% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
CBRE can refer to:Canadian Brotherhood of Railway Employees, a railway trade union in Canada Chemical, Biological, Radiological and Explosive Defence Group, a counter-terrorism unit in Singapore CBRE Group, a multinational real estate corporation Certified broadcast radio engineer, a professional title regulated by The Society of Broadcast Engineers
ABBV vs CBRE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $10.5B |
| Net Profit | $697.0M | $318.0M |
| Gross Margin | — | 17.6% |
| Operating Margin | 26.6% | 4.9% |
| Net Margin | 4.6% | 3.0% |
| Revenue YoY | 9.9% | 22.0% |
| Net Profit YoY | -46.0% | 95.1% |
| EPS (diluted) | $0.39 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | $10.5B | ||
| Q4 25 | $16.6B | $11.5B | ||
| Q3 25 | $15.8B | $10.1B | ||
| Q2 25 | $15.4B | $9.6B | ||
| Q1 25 | $13.3B | $8.8B | ||
| Q4 24 | $15.1B | $10.2B | ||
| Q3 24 | $14.5B | $8.8B | ||
| Q2 24 | $14.5B | $8.2B |
| Q1 26 | $697.0M | $318.0M | ||
| Q4 25 | $1.8B | $416.0M | ||
| Q3 25 | $186.0M | $363.0M | ||
| Q2 25 | $938.0M | $215.0M | ||
| Q1 25 | $1.3B | $163.0M | ||
| Q4 24 | $-22.0M | $487.0M | ||
| Q3 24 | $1.6B | $225.0M | ||
| Q2 24 | $1.4B | $130.0M |
| Q1 26 | — | 17.6% | ||
| Q4 25 | 72.6% | 17.3% | ||
| Q3 25 | 66.4% | 17.7% | ||
| Q2 25 | 71.8% | 17.1% | ||
| Q1 25 | 70.0% | 17.1% | ||
| Q4 24 | 70.9% | 18.7% | ||
| Q3 24 | 70.9% | 18.1% | ||
| Q2 24 | 70.9% | 17.6% |
| Q1 26 | 26.6% | 4.9% | ||
| Q4 25 | 27.3% | 5.4% | ||
| Q3 25 | 12.1% | 4.8% | ||
| Q2 25 | 31.7% | 3.9% | ||
| Q1 25 | 28.0% | 3.1% | ||
| Q4 24 | -9.9% | 5.8% | ||
| Q3 24 | 26.5% | 4.2% | ||
| Q2 24 | 27.6% | 3.0% |
| Q1 26 | 4.6% | 3.0% | ||
| Q4 25 | 10.9% | 3.6% | ||
| Q3 25 | 1.2% | 3.6% | ||
| Q2 25 | 6.1% | 2.2% | ||
| Q1 25 | 9.6% | 1.9% | ||
| Q4 24 | -0.1% | 4.8% | ||
| Q3 24 | 10.8% | 2.5% | ||
| Q2 24 | 9.5% | 1.6% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | $1.38 | ||
| Q3 25 | $0.10 | $1.21 | ||
| Q2 25 | $0.52 | $0.72 | ||
| Q1 25 | $0.72 | $0.54 | ||
| Q4 24 | $-0.03 | $1.58 | ||
| Q3 24 | $0.88 | $0.73 | ||
| Q2 24 | $0.77 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.7B |
| Total DebtLower is stronger | — | $5.1B |
| Stockholders' EquityBook value | — | $8.9B |
| Total Assets | — | $30.2B |
| Debt / EquityLower = less leverage | — | 0.57× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.7B | ||
| Q4 25 | $5.3B | $1.9B | ||
| Q3 25 | $5.7B | $1.7B | ||
| Q2 25 | $6.5B | $1.4B | ||
| Q1 25 | $5.2B | $1.4B | ||
| Q4 24 | $5.6B | $1.1B | ||
| Q3 24 | $7.3B | $1.0B | ||
| Q2 24 | $13.2B | $928.0M |
| Q1 26 | — | $5.1B | ||
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — |
| Q1 26 | — | $8.9B | ||
| Q4 25 | $-3.3B | $8.9B | ||
| Q3 25 | $-2.6B | $8.5B | ||
| Q2 25 | $-183.0M | $8.3B | ||
| Q1 25 | $1.4B | $8.3B | ||
| Q4 24 | $3.3B | $8.4B | ||
| Q3 24 | $6.0B | $8.7B | ||
| Q2 24 | $6.8B | $8.4B |
| Q1 26 | — | $30.2B | ||
| Q4 25 | $134.0B | $30.9B | ||
| Q3 25 | $133.9B | $28.6B | ||
| Q2 25 | $137.2B | $27.7B | ||
| Q1 25 | $136.2B | $26.4B | ||
| Q4 24 | $135.2B | $24.4B | ||
| Q3 24 | $143.4B | $24.8B | ||
| Q2 24 | $141.9B | $23.5B |
| Q1 26 | — | 0.57× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-825.0M |
| Free Cash FlowOCF − Capex | — | $-605.0M |
| FCF MarginFCF / Revenue | — | -5.7% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | — | -2.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-825.0M | ||
| Q4 25 | $5.2B | $1.2B | ||
| Q3 25 | $7.0B | $827.0M | ||
| Q2 25 | $5.2B | $57.0M | ||
| Q1 25 | $1.6B | $-546.0M | ||
| Q4 24 | $7.0B | $1.3B | ||
| Q3 24 | $5.4B | $573.0M | ||
| Q2 24 | $2.3B | $287.0M |
| Q1 26 | — | $-605.0M | ||
| Q4 25 | $4.9B | $1.1B | ||
| Q3 25 | $6.6B | $743.0M | ||
| Q2 25 | $4.9B | $-17.0M | ||
| Q1 25 | $1.4B | $-610.0M | ||
| Q4 24 | $6.8B | $1.2B | ||
| Q3 24 | $5.2B | $494.0M | ||
| Q2 24 | $2.0B | $220.0M |
| Q1 26 | — | -5.7% | ||
| Q4 25 | 29.4% | 9.4% | ||
| Q3 25 | 42.1% | 7.4% | ||
| Q2 25 | 31.7% | -0.2% | ||
| Q1 25 | 10.5% | -7.0% | ||
| Q4 24 | 44.7% | 12.2% | ||
| Q3 24 | 35.9% | 5.6% | ||
| Q2 24 | 14.0% | 2.7% |
| Q1 26 | — | 0.8% | ||
| Q4 25 | 2.0% | 1.3% | ||
| Q3 25 | 2.4% | 0.8% | ||
| Q2 25 | 1.7% | 0.8% | ||
| Q1 25 | 1.8% | 0.7% | ||
| Q4 24 | 1.9% | 0.9% | ||
| Q3 24 | 1.7% | 0.9% | ||
| Q2 24 | 1.7% | 0.8% |
| Q1 26 | — | -2.59× | ||
| Q4 25 | 2.87× | 2.94× | ||
| Q3 25 | 37.76× | 2.28× | ||
| Q2 25 | 5.49× | 0.27× | ||
| Q1 25 | 1.27× | -3.35× | ||
| Q4 24 | — | 2.75× | ||
| Q3 24 | 3.49× | 2.55× | ||
| Q2 24 | 1.66× | 2.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
